Luo SX - Search Results

1

Retraction Note: Evaluation of PAX8 expression promotes the proliferation of stomach Cancer cells.

Bie LY, Li N, Deng WY, Lu XY, Guo P, Luo SX. Bie LY, et al. Among authors: luo sx. BMC Mol Cell Biol. 2021 Jun 1;22(1):31. doi: 10.1186/s12860-021-00372-8. BMC Mol Cell Biol. 2021. PMID: 34074245 Free PMC article. No abstract available.

2

[The study of anti-tumor effect of Tetrandrine combined with Nedaplatin on human liver cancer cell line 7402].

Deng WY, Luo SX, Zhou MQ, Li N, Chen XB, Han LL. Deng WY, et al. Among authors: luo sx. Zhong Yao Cai. 2008 Oct;31(10):1522-5. Zhong Yao Cai. 2008. PMID: 19230406 Chinese.

3

Hemangioblastic characteristics of human adipose tissue-derived adult stem cells in vivo.

Fang B, Luo S, Song Y, Li N, Cao Y. Fang B, et al. Arch Med Res. 2009 May;40(4):311-7. doi: 10.1016/j.arcmed.2009.04.007. Epub 2009 Jun 4. Arch Med Res. 2009. PMID: 19608022

4

Intermittent dosing of G-CSF to ameliorate carbon tetrachloride-induced liver fibrosis in mice.

Fang B, Luo S, Song Y, Li N, Li H, Zhao RC. Fang B, et al. Toxicology. 2010 Mar 30;270(1):43-8. doi: 10.1016/j.tox.2009.12.002. Epub 2009 Dec 11. Toxicology. 2010. PMID: 20005281

5

Molecular mechanism of indirubin-3'-monoxime and Matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line.

Luo SX, Deng WY, Wang XF, Lü HF, Han LL, Chen BB, Chen XB, Li N. Luo SX, et al. Chin Med J (Engl). 2013 Mar;126(5):925-9. Chin Med J (Engl). 2013. PMID: 23489803

6

Clinical observation and therapeutic evaluation of Rh-endostatin combined with DP regimen in treating patients with advanced esophageal cancer.

Deng WY, Song T, Li N, Luo SX, Li X. Deng WY, et al. Among authors: luo sx. Asian Pac J Cancer Prev. 2014;15(16):6565-70. doi: 10.7314/apjcp.2014.15.16.6565. Asian Pac J Cancer Prev. 2014. PMID: 25169488 Free article. Clinical Trial.

7

Phosphorylated insulin-like growth factor-1 receptor expression predicts poor prognosis of Chinese patients with gastric cancer.

Deng WY, Li N, Wan XB, Luo SX, Zhang YW. Deng WY, et al. Among authors: luo sx. Med Oncol. 2014 Dec;31(12):141. doi: 10.1007/s12032-014-0141-2. Epub 2014 Oct 28. Med Oncol. 2014. PMID: 25348345

8

Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.

Li N, Deng W, Ma J, Wei B, Guo K, Shen W, Zhang Y, Luo S. Li N, et al. Med Oncol. 2015 Jan;32(1):433. doi: 10.1007/s12032-014-0433-6. Epub 2014 Dec 10. Med Oncol. 2015. PMID: 25491144

9

MicroRNA-146a rs2910164 G/C polymorphism and gastrointestinal cancer susceptibility: a meta-analysis based on East Asian population.

Chen BB, Cao XG, Chen XB, Ma YJ, Deng WY, Li N, Huang JX, Luo SX, Zhao EJ. Chen BB, et al. Among authors: luo sx. J Cancer Res Ther. 2014 Dec;10 Suppl:252-5. doi: 10.4103/0973-1482.151462. J Cancer Res Ther. 2014. PMID: 25693929 Free article.

10

Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Wei C, Deng WY, Li N, Shen W, Zhang C, Liu JY, Luo SX. Wei C, et al. Among authors: luo sx. Dig Dis Sci. 2015 Sep;60(9):2771-6. doi: 10.1007/s10620-015-3681-1. Epub 2015 May 5. Dig Dis Sci. 2015. PMID: 25939544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters